Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Whitman

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Immunity|October 31, 2020
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike ProteinAndrew P Ferretti, Tomasz Kula, Yifan Wang, et al.
Cancer Discovery|March 17, 2021
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALLMatthew A Nix, Kamal Mandal, Huimin Geng, et al.
The Lancet. Infectious Diseases|March 14, 2022
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 studyJames Welker, Juan D Pulido, Andrew T Catanzaro, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
The New England Journal of Medicine|June 3, 2011
gp100 peptide vaccine and interleukin-2 in patients with advanced melanomaDouglas J Schwartzentruber, David H Lawson, Jon M Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2021
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaAmod A Sarnaik, Omid Hamid, Nikhil I Khushalani, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
Journal for Immunotherapy of Cancer|June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Immunity|October 31, 2020
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike ProteinAndrew P Ferretti, Tomasz Kula, Yifan Wang, et al.
Cancer Discovery|March 17, 2021
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALLMatthew A Nix, Kamal Mandal, Huimin Geng, et al.
The Lancet. Infectious Diseases|March 14, 2022
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 studyJames Welker, Juan D Pulido, Andrew T Catanzaro, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
The New England Journal of Medicine|June 3, 2011
gp100 peptide vaccine and interleukin-2 in patients with advanced melanomaDouglas J Schwartzentruber, David H Lawson, Jon M Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2021
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaAmod A Sarnaik, Omid Hamid, Nikhil I Khushalani, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
Journal for Immunotherapy of Cancer|June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 11